Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance ...

How is artificial intelligence (AI) being utilized in the field of immunodiagnostics? AI is revolutionizing immunodiagnostics by accelerating the discovery and optimization of antibody reagents.

The anti-CALB2 antibody gives labs a reliable way to find caltrentinin with clarity and control. From brain mapping to tumor ...

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

The global research antibodies and reagents market is expected to grow from $12.40 billion in 2021 to $13.19 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war ...

DUBLIN--(BUSINESS WIRE)--The "Global Monoclonal Antibody Diagnostic Reagent Market: Analysis By Tests, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to ...

Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, today announced the ...

The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by increasing demand for high-specificity antibodies, assay-ready reagents, and ...

The vast majority of reagent antibodies are produced from hybridomas. Hybridomas suffer from many limitations: they can undergo genetic drift leading to batch-to-batch variability; they can be ...

Research Antibodies & Reagents Market in terms of revenue was estimated to be worth $11.8 Billion in 2023 and is poised to reach $16.2 Billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 ...